Project Details

Perform another search<<First  <Prev [5314 of 5967Next>  Last>>

CWSF 2006 - Saguenay, Québec

Print/Download as PDF

David Wang

Engineering A Cure for Diabetes
Region:London District
City:London, ON
School:A.B. Lucas S.S.
Abstract:This project investigated the feasibility of the cost-effective production of a human regulatory cytokine, IL-13 in transgenic plants for the treatment of Type 1 diabetes (T1D). Transgenic plants producing large amounts of IL-13 were generated. In vitro bioassays demonstrated that the plant-derived IL-13 effectively induced the proliferation of T1D-associated T-lymphocytes. Thus, this study represents a novel, low-cost, oral, immune-based therapy for diabetes.

Awards Value
Honourable Mention - Biotechnology & Pharmaceutical Sciences
Sponsor: Rx&D Health Research Foundation